Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Amgen Faces Investigation Over Data Breach and Potential Violation of Laws

Guavy AI Editorial Team
Instruments
AMGN
Share

The California-based biotechnology company Amgen Inc. is under investigation for a data breach that allowed unauthorized access to sensitive information of individuals affiliated with the company.

Amgen disclosed in its SEC Form 8-K filing that it identified unauthorized activity in its cloud storage systems hosted by external service providers in July 2026.

The company described the data breach as 'material' but has not disclosed the number of individuals impacted or directly notified them, which may have violated state and federal laws.

More on Stocks

Stocks 1m ago

3M Stake Reduced by Segall Bryant & Hamill LLC

Stocks 1m ago

Bezos Sells Billions as Amazon Hits $3 Trillion Milestone

Stocks 1m ago

Amazon Fixes AZW3 E-book Refresh Issues in Latest Kindle Update

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Real-time market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy